{"id":559345,"date":"2021-08-24T17:38:01","date_gmt":"2021-08-24T17:38:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=559345"},"modified":"2021-08-24T17:38:01","modified_gmt":"2021-08-24T17:38:01","slug":"aortic-stenosis-market-industry-analysis-epidemiology-pipeline-drugs-and-companies-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/aortic-stenosis-market-industry-analysis-epidemiology-pipeline-drugs-and-companies-by-delveinsight_559345.html","title":{"rendered":"Aortic Stenosis Market: Industry Analysis, Epidemiology, Pipeline, Drugs and Companies by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1629788409.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Aortic Stenosis Market: Industry Analysis, Epidemiology, Pipeline, Drugs and Companies by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1629788409.jpeg\" alt=\"Aortic Stenosis Market: Industry Analysis, Epidemiology, Pipeline, Drugs and Companies by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Aortic Stenosis Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/aortic-stenosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Aortic stenosis<\/a><\/strong> is the obstruction of blood flow across the aortic valve. Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25% at 1 year and 50% at 2 years. Symptoms of aortic stenosis usually develop gradually after an asymptomatic latent period of 10-20 years.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s&nbsp;<strong>&lsquo;&lsquo;Aortic Stenosis Market Insights, Epidemiology and Market Forecast-2030&rsquo;&#8217;<\/strong>&nbsp;report delivers an in-depth understanding of the Aortic Stenosis, historical and forecasted epidemiology as well as the Aortic Stenosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some key facts of <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/aortic-stenosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Aortic Stenosis Market<\/a>:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>As per a study by Pujari et al. (2021), the prevalence of calcific aortic stenosis is about 1% to 2% in patients aged 65 or more, 12% in patients aged 65 or more, and about 3.4% of patients aged greater than 75 have severe aortic stenosis.<\/li>\n<li>The prevalence of aortic sclerosis ranges from 9-45% in patients with a mean age of 54 to 81 and increases with age.<\/li>\n<li>According to a journal, the prevalence in Japan of any valve disease is 2.5%. Of those with valve disease, about 0.4% have aortic stenosis.<\/li>\n<li>According to Grave et al. (2020), in 2017, the guidelines of the European Society of Cardiology and the European Association for Cardio\u2010Thoracic Surgery recommended SAVR or TAVI, depending on symptoms, AS severity<strong>, comorbidities, and the clinical evaluation of the heart team.<\/strong><\/li>\n<li>&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Scope of the Aortic Stenosis Market Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Aortic Stenosis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Aortic Stenosis epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Aortic Stenosis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Aortic Stenosis market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Aortic Stenosis market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Page: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/aortic-stenosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/aortic-stenosis-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of Aortic Stenosis Companies are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>MyoKardia<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/aortic-stenosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Aortic Stenosis therapies<\/a> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Mavacamten<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Page: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/aortic-stenosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/aortic-stenosis-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Aortic Stenosis<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Aortic Stenosis<\/p>\n<p style=\"text-align: justify;\">4. Aortic Stenosis: Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">4.1. Aortic Stenosis Total Market Share (%) Distribution in 2018<\/p>\n<p style=\"text-align: justify;\">4.2. Aortic Stenosis Total Market Share (%) Distribution in 2030<\/p>\n<p style=\"text-align: justify;\">5. Aortic Stenosis: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">5.1. Introduction<\/p>\n<p style=\"text-align: justify;\">5.2. Sign and Symptoms<\/p>\n<p style=\"text-align: justify;\">5.3. Pathophysiology<\/p>\n<p style=\"text-align: justify;\">5.4. Risk Factors<\/p>\n<p style=\"text-align: justify;\">5.5. Diagnosis<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Aortic Stenosis Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">7.1. Epidemiology Key Findings<\/p>\n<p style=\"text-align: justify;\">7.2. Assumptions and Rationale: 7MM<\/p>\n<p style=\"text-align: justify;\">7.3. Epidemiology Scenario: 7MM<\/p>\n<p style=\"text-align: justify;\">7.3.1. Aortic Stenosis Epidemiology Scenario in the 7MM (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.4. United States Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.4.1. Aortic Stenosis Epidemiology Scenario in the United States (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5. EU-5 Country-wise Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.1. Germany Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.1.1. Aortic Stenosis Epidemiology Scenario in Germany (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.2. France Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.2.1. Aortic Stenosis Epidemiology Scenario in France (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.3. Italy Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.3.1. Aortic Stenosis Epidemiology Scenario in Italy (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.4. Spain Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.4.1. Aortic Stenosis Epidemiology Scenario in Spain (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.5. United Kingdom Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.5.1. Aortic Stenosis Epidemiology Scenario in the United Kingdom (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.6. Japan Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.6.1. Aortic Stenosis Epidemiology Scenario in Japan (2018-2030)<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">8.1. Aortic Stenosis Treatment and Management<\/p>\n<p style=\"text-align: justify;\">8.2. Aortic Stenosis Treatment Algorithm<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Aortic Stenosis Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">11.1. List of Marketed Products in the 7MM<\/p>\n<p style=\"text-align: justify;\">11.2. Drug Name: Company Name<\/p>\n<p style=\"text-align: justify;\">11.2.1. Product Description<\/p>\n<p style=\"text-align: justify;\">11.2.2. Regulatory Milestones<\/p>\n<p style=\"text-align: justify;\">11.2.3. Other Developmental Activities<\/p>\n<p style=\"text-align: justify;\">11.2.4. Pivotal Clinical Trials<\/p>\n<p style=\"text-align: justify;\">11.2.5. Summary of Pivotal Clinical Trial<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12.1. Key Cross<\/p>\n<p style=\"text-align: justify;\">12.2. Drug Name: Company Name<\/p>\n<p style=\"text-align: justify;\">12.2.1. Product Description<\/p>\n<p style=\"text-align: justify;\">12.2.2. Other Developmental Activities<\/p>\n<p style=\"text-align: justify;\">12.2.3. Clinical Development<\/p>\n<p style=\"text-align: justify;\">12.2.4. Safety and Efficacy<\/p>\n<p style=\"text-align: justify;\">12.2.5. Product Profile<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">13. Aortic Stenosis: Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">13.1. Key Findings<\/p>\n<p style=\"text-align: justify;\">13.2. Aortic Stenosis Market Size in 7MM<\/p>\n<p style=\"text-align: justify;\">13.3. Aortic Stenosis Market Size by Therapies in the 7MM<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">15.1. United States: Market Size<\/p>\n<p style=\"text-align: justify;\">15.1.1. Aortic Stenosis Total Market Size in the United States<\/p>\n<p style=\"text-align: justify;\">15.1.2. Aortic Stenosis Market Size by Therapies in the United States<\/p>\n<p style=\"text-align: justify;\">15.2. EU-5 countries: Market Size and Outlook<\/p>\n<p style=\"text-align: justify;\">15.3. Germany Market Size<\/p>\n<p style=\"text-align: justify;\">15.3.1. Aortic Stenosis Total Market Size in Germany<\/p>\n<p style=\"text-align: justify;\">15.3.2. Aortic Stenosis Market Size by Therapies in Germany<\/p>\n<p style=\"text-align: justify;\">15.4. France Market Size<\/p>\n<p style=\"text-align: justify;\">15.4.1. Aortic Stenosis Total Market Size in France<\/p>\n<p style=\"text-align: justify;\">15.4.2. Aortic Stenosis Market Size by Therapies in France<\/p>\n<p style=\"text-align: justify;\">15.5. Italy Market Size<\/p>\n<p style=\"text-align: justify;\">15.5.1. Aortic Stenosis Total Market Size in Italy<\/p>\n<p style=\"text-align: justify;\">15.5.2. Aortic Stenosis Market Size by Therapies in Italy<\/p>\n<p style=\"text-align: justify;\">15.6. Spain Market Size<\/p>\n<p style=\"text-align: justify;\">15.6.1. Aortic Stenosis Total Market Size in Spain<\/p>\n<p style=\"text-align: justify;\">15.6.2. Aortic Stenosis Market Size by Therapies in Spain<\/p>\n<p style=\"text-align: justify;\">15.7. United Kingdom Market Size<\/p>\n<p style=\"text-align: justify;\">15.7.1. Aortic Stenosis Total Market Size in the United Kingdom<\/p>\n<p style=\"text-align: justify;\">15.7.2. Aortic Stenosis Market Size by Therapies in the United Kingdom<\/p>\n<p style=\"text-align: justify;\">15.8. Japan Market Outlook<\/p>\n<p style=\"text-align: justify;\">15.8.1. Japan Market Size<\/p>\n<p style=\"text-align: justify;\">15.8.2. Aortic Stenosis Total Market Size in Japan<\/p>\n<p style=\"text-align: justify;\">15.8.3. Aortic Stenosis Market Size by Therapies in Japan<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Aortic Stenosis<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">20.1. Bibliography<\/p>\n<p style=\"text-align: justify;\">20.2. Report Methodology<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Detailed TOC: https:\/\/www.delveinsight.com\/sample-request\/aortic-stenosis-market<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=aortic-stenosis-market-industry-analysis-epidemiology-pipeline-drugs-and-companies-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/aortic-stenosis-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/aortic-stenosis-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/aortic-stenosis-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=aortic-stenosis-market-industry-analysis-epidemiology-pipeline-drugs-and-companies-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aortic Stenosis Market Aortic stenosis is the obstruction of blood flow across the aortic valve. Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25% at 1 year and 50% at 2 &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/aortic-stenosis-market-industry-analysis-epidemiology-pipeline-drugs-and-companies-by-delveinsight_559345.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-559345","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/559345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=559345"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/559345\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=559345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=559345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=559345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}